Updated Jul 16, 2026
Satvat Ali J. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-06-10 | CHRS | Coherus BioSciences, Inc. | A — Grant or award | 30.0K | $0.00 | |
| 2024-12-31 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 39.9K | $26.21 | $1.04M |
| 2024-12-31 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 39.9K | $16.68 | $665K |
| 2024-12-31 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 79.7K | $10.99 | $876K |
Satvat Ali J. is a corporate insider — currently tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Satvat Ali J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.